What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q1 2020?

163 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 48,932,355
Total 13F shares: 22,843,303
Share change: +1,934,781
Total reported value: $1,344,655,517
Put/Call ratio: 64%
Price per share: $58.83
Number of holders: 163
Value change: +$45,174,721
Number of buys: 104
Number of sells: 86

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 05464T104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	4.4%	2,160,246	$223,283,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.3%	1,606,991	$166,099,000	—	31 Dec 2019	13F
VHCP Management III, LLC	13F	Company	3.2%	1,547,994	$160,001,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	2.8%	1,361,944	$140,770,000	—	31 Dec 2019	13F
RTW INVESTMENTS, LP	13F	Company	2.1%	1,026,813	$106,131,000	—	31 Dec 2019	13F
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	2%	1,000,580	$103,420,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	1.7%	829,757	$85,764,000	—	31 Dec 2019	13F
VHCP Management II, LLC	13F	Company	1.6%	785,981	$81,239,000	—	31 Dec 2019	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	1.3%	654,239	$67,622,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	1.3%	629,676	$65,083,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	1.2%	611,359	$63,190,000	—	31 Dec 2019	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.2%	607,500	$62,791,000	—	31 Dec 2019	13F
Cormorant Asset Management, LP	13F	Company	1.2%	600,000	$62,016,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	577,643	$59,705,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1%	504,738	$52,170,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1%	503,354	$52,027,000	—	31 Dec 2019	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.9%	442,222	$45,708,000	—	31 Dec 2019	13F
HealthCor Management, L.P.	13F	Company	0.84%	408,617	$42,235,000	—	31 Dec 2019	13F
STIFEL FINANCIAL CORP	13F	Company	0.83%	404,145	$41,772,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.75%	368,021	$38,038,000	—	31 Dec 2019	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.75%	367,816	$38,017,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.74%	360,440	$37,256,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.68%	332,567	$34,374,000	—	31 Dec 2019	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.56%	275,717	$28,498,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.55%	267,825	$27,682,000	—	31 Dec 2019	13F
WINTON GROUP Ltd	13F	Company	0.46%	227,526	$23,517,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.42%	203,808	$21,066,000	—	31 Dec 2019	13F
Ghost Tree Capital, LLC	13F	Company	0.41%	200,000	$20,672,000	—	31 Dec 2019	13F
FIL Ltd	13F	Company	0.41%	199,151	$20,585,000	—	31 Dec 2019	13F
Walleye Capital LLC	13F	Company	0.35%	170,268	$17,599,000	—	31 Dec 2019	13F
JANE STREET GROUP, LLC	13F	Company	0.34%	167,656	$17,329,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	160,178	$16,556,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.3%	146,625	$15,155,000	—	31 Dec 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.28%	138,032	$14,267,000	—	31 Dec 2019	13F
Logos Global Management LP	13F	Company	0.26%	124,937	$12,913,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.21%	101,176	$10,457,000	—	31 Dec 2019	13F
Caption Management, LLC	13F	Company	0.18%	88,400	$9,137,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.17%	83,463	$8,627,000	—	31 Dec 2019	13F
Informed Momentum Co LLC	13F	Company	0.15%	71,556	$7,396,000	—	31 Dec 2019	13F
CSS LLC/IL	13F	Company	0.14%	69,548	$7,188,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.14%	68,948	$7,126,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.13%	65,438	$6,764,000	—	31 Dec 2019	13F
MOODY ALDRICH PARTNERS LLC	13F	Company	0.13%	62,189	$6,428,000	—	31 Dec 2019	13F
ROYCE & ASSOCIATES LP	13F	Company	0.12%	60,100	$6,212,000	—	31 Dec 2019	13F
CWM, LLC	13F	Company	0.19%	91,417	$6,167,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.12%	56,352	$5,824,000	—	31 Dec 2019	13F
Walleye Trading LLC	13F	Company	0.11%	55,456	$5,732,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.1%	50,770	$5,248,000	—	31 Dec 2019	13F
GROUP ONE TRADING LLC	13F	Company	0.1%	50,431	$5,213,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.1%	48,942	$5,059,000	—	31 Dec 2019	13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q1 2020

As of 31 Mar 2020, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,843,303 shares. The largest 10 holders included BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, VR Adviser, LLC, CITADEL ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 163 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

168

Q1 2020 holders

163

Holder diff

-5

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.